The total number of haemangioblastomas observed in these patients was 93, of which 73% were located in the posterior fossa, 26% in the spinal canal, and 1 % was supratentorial (table 2). Sixty seven haemangioblastomas were identified by biopsy, nine were found at necropsy, and 17 were diagnosed by neuroradiology. Seventy-five per cent of the tumours were cystic and 25% were solid; in the posterior fossa, 86% were cystic and in the spine, 46%. The supratentorial lesion was solid. Histopathology showed characteristic haemangioblastomas (World Health Organisation grade I) in all cases. No significant difference in histopathological appearance was noted between sporadic haemangioblastomas and those associated with HLS.
Multifocal haemangioblastomas occurred in 18 patients (42%); of these, eight have died. At the time of the original diagnosis, multiple lesions were found in nine (21%). Five patients with haemangioblastoma had surgery twice; two, three times; one, four times, and one, six times (fig 1) .
In contrast, none of 51 patients (mean age 47 years, 18 female, 33 male) presenting with a sporadic CNS haemangioblastoma during the last 13 years developed multiple lesions; all these subjects underwent screening for HLS according to the programme in table 1. Their mean age was 47-2 years and is significantly different (p < 0 05) from the mean age of the HLS carriers (33 9) years.
Tumours were surgically removed when signs of increased intracranial pressure or focal neurological deficits occurred or neuroradiological examination revealed evidence for rapid growth. When MRI scans showed lesions compatible with CNS haemangioblastoma in 14 patients, clinical follow-up revealed no signs of tumour progression. Surgery has not been performed on these patients so far.
Post-operative gadolinium-enhanced MRI was conducted annually in cases with a solitary tumour, and at six-monthly intervals in patients with multifocal lesions. Since the introduction of microsurgery post-operative outcome has been generally good. Of 19 patients, one died of multilocular haemangioblastomas, one had residual paraparesis and one had quadriplegia caused by spinal lesions. The other patients recovered completely.
Polycythaemia, a well-documented feature in CNS haemangioblastoma was present in only five of 43 cases (12%).
Metastases
Metastatic involvement of the CNS occurred in two HLS patients. The first was a 42 year old woman with a history of a renal cell carcinoma. Two years after nephrectomy this patient experienced the symptoms of Brown-Sequard syndrome, caused by a mass in the D4-region (fig 2a) . Histopathology disclosed metastatic renal cell cancer. To distinguish between clear cell carcinoma and haemangioblastoma, immunocytochemical reactions were carried out with antibodies to the pan-epithelial antigen Lu-5, a marker for cells of epithelial origin which is not expressed in haemangioblastomas. This reaction was strongly positive, confirming the diagnosis of metastatic carcinoma (fig 2b) . The second was a 60 year old woman with bilateral retinal angiomatosis and a long history of maldigestion and malabsorption who developed severe pneumonia and died. Major findings at necropsy included isletcell carcinoma of the pancreas with metastases to the liver, the cerebellum and the dura mater, and renal cell cancer. Neumann located in the posterior fossa but these qS haemangio-tumours may also be found in other regions of cell carcinoma the CNS. The incidence of haemangioblastoical problem. To ma was 21%, 53%, 57% and 72% respectively, lasms, reticulin reported in the previously published studies on !s to keratin-large kindreds6 or small series of families with sed. We have HLS.89 In the present series, CNS haemanh, on the basis gioblastoma was found in 44% of the HLS iological and gene carriers. s, had to be Interestingly, we have observed several families without a single instance of CNS haemangioblastoma. The genetic basis for the n Hippel-Lindau pattern of the manifestations in different kindreds is, at present, unknown.4 f 97 HLS gene
Haemangioblastomas of the CNS are of ilastomas. Other prognostic significance, as they-tend to induce as follows: reti-the formation of expanding cysts which may 9 of 43), renal cause life-threatening complications and often 47% (20 of 43), require emergency treatment. Cerebellar hae-(2 of 43), pan-mangioblastomas were the major cause of and epididymal death in 82% of the patients in the present 20 21 In conclusion, CNS haemangioblastomas constitute a major manifestation of HLS, are found in about 50% of gene carriers, tend to develop 15 years earlier compared with sporadic haemangioblastoma, and have a striking tendency for multiple occurrence in HLS patients. Although microsurgical techniques have considerably improved the postoperative outcome in patients with CNS haemangioblastoma, multifocal tumour development and recurrence are still serious problems. Whether novel therapeutic strategies, such as selective embolisation of feeding vessels, can overcome some of these problems remains to be determined.
